Seres Therapeutics (MCRB) Tops Q3 EPS by 94c

Seres Therapeutics (NASDAQ: MCRB) reported Q3 EPS of $0.94. Revenue for the quarter came in at $350 thousand.

For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• Tractor Supply and Starlink team up to expand rural broadband via 4-H
• Uranium Royalty Corp. sets shareholder vote on $1.14B Sweetwater deal